MoneyWorks4Me

Indoco Remedies - Quaterly Results

09 Aug 2022 Evaluate
The company witnessed a 5.54% growth in the revenue at Rs. 4079.00 millions for the quarter ended June 2022 as compared to Rs. 3864.90 millions during the year-ago period.A slender decline of -2.88% was recorded to Rs. 384.70  millions from Rs. 396.10 millions in the corresponding previous quarter.A decline of 724.30 millions was observed in the OP in the quarter ended June 2022 from 876.70 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 4079.00 3864.90 5.54 4079.00 3864.90 5.54 15397.20 12403.00 24.14
Other Income 11.30 8.60 31.40 11.30 8.60 31.40 23.20 31.20 -25.64
PBIDT 724.30 876.70 -17.38 724.30 876.70 -17.38 3293.20 2266.90 45.27
Interest 41.30 42.30 -2.36 41.30 42.30 -2.36 141.40 222.20 -36.36
PBDT 683.00 834.40 -18.14 683.00 834.40 -18.14 3151.80 2044.70 54.14
Depreciation 201.00 222.30 -9.58 201.00 222.30 -9.58 789.50 731.20 7.97
PBT 482.00 612.10 -21.25 482.00 612.10 -21.25 2362.30 1313.50 79.85
TAX 97.30 216.00 -54.95 97.30 216.00 -54.95 817.10 389.60 109.73
Deferred Tax -56.70 -57.60 -1.56 -56.70 -57.60 -1.56 -115.20 4.90 -2451.02
PAT 384.70 396.10 -2.88 384.70 396.10 -2.88 1545.20 923.90 67.25
Equity 184.30 184.30 0.00 184.30 184.30 0.00 184.30 184.30 0.00
PBIDTM(%) 17.76 22.68 -21.72 17.76 22.68 -21.72 21.39 18.28 17.02
Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..